Dow Down 0.22% Nasdaq Up 0.14%

Advaxis, Inc. (ADXS)

-NasdaqCM
3.25 Up 0.10(3.17%) Aug 22, 4:00PM EDT
|After Hours : 3.30 Up 0.05 (1.54%) Aug 22, 7:06PM EDT
Prev Close:3.15
Open:3.24
Bid:2.90 x 200
Ask:3.35 x 200
1y Target Est:13.50
Beta:1.11
Next Earnings Date:N/A
Day's Range:3.08 - 3.28
52wk Range:2.46 - 11.70
Volume:428,625
Avg Vol (3m):170,309
Market Cap:62.64M
P/E (ttm):N/A
EPS (ttm):-2.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSUp 3.17%62.64M
BVTI 0.00%N/A
DNDNDown 1.86%205.17M
VICLUp 1.60%112.53M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):60.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Jul-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback